This week, the Senate Finance Committee launched a probe into educational grants donated by Johnson & Johnson to promote the non-label use of Propulsid for kids, even though some company employees were concerned about the safety of the long-gone drug.

The inquiry comes on the heels of an awesome New York Times article I posted last week that describes how Johnson & Johnson negotiated with the FDA behind closed doors for additional safety warnings to keep the real toxic truth about Propulsid quiet.

And to keep the money machine going, Johnson & Johnson kicked in some cash to finance a pair of organizations that supported the use of Propulsid by kids -- to the tune of nearly $1.5 million -- as well as a book about it.

The letter, sent yesterday by Sens. Charles Grassley (R-Iowa) and Max Baucus (D-Montana), cited the New York Times piece and asked for additional information about the grants: Who received them, what they were used for and how much they were.

For the sake of the health of Americans, I truly hope Congress will get to the bottom of this problem. Considering the mega-drug companies have spent almost $800 million on lobbying alone since 1998, however, I remain very skeptical you can really count on them or anyone else to look after your best interests when it comes to your health.

Just another of the many reasons I launched this Web site, to transform the conventional medical paradigm from one addicted to drugs and quick-fix cures to one focused on treating the true causes of disease.

Wilmington Star-News July 6, 2005

New York Times July 6, 2005 Registration Required